Foot and Mouth Disease (FMD) Vaccine Market Will Accomplish Outstanding USD 3.0 Billion Figure By 2025
Global Footand Mouth Disease (FMD) Vaccine Market is anticipated to reach USD 3.0 billion by 2025. Foot-and-Mouth disease, also termed as “Hoof-and-Mouth Disease” implies an infectious and contagious viral disease that affects cloven-hoofed animals, involving wild and domestic bovids. The after-effects of foot and mouth disease include high fever that lasts for two to six days. The symptoms include blisters on the feet and inside the mouth. Foot and Mouth Disease (FMD) Vaccine has significant economic impact.
The
factors that propel the growth of the market include changing lifestyle coupled
with change in food preference, increasing awareness among people, and
increased acceptance of oil-based vaccines due to their developed
effectiveness. On the other hand, there are factors that may hamper the growth of
the market such as less immunity, high cost, and instability at room
temperature (3-8 ° C). Foot and Mouth Disease Vaccine Market is anticipated to
grow at a significant CAGR of 8.1% in the upcoming period as the scope, product
types, and its applications are increasing across the globe.
Foot
and Mouth Disease (FMD) Vaccine Industry may be explored by product type,
application, and geography. The market may be explored by product type as
Conventional vaccines, and Emergency vaccines. The “Conventional vaccines” section
dominated the FMD Vaccine Market in 2016 and is anticipated to maintain its
dominance by 2025 owing to an increasing penetration of oil-based vaccines due
to their higher efficacy and long-term effectiveness.
Request Sample Copy of This Market Research @
Foot
and Mouth Disease (FMD) Vaccine Market may be explored by application as Sheep
and goats, Cattle, and Pigs. The “Cattle” section dominated the Foot and Mouth
Disease Vaccine industry in 2016 and is anticipated to maintain its dominance
by 2025 owing to improved demand for livestock products. Asia-Pacific accounted
for the major share of the Foot and Mouth Disease (FMD) Vaccine Market Size in
2016 and will continue to lead in the forthcoming period. The factors that
could attribute to the growth include growing R&D investment. Asia-Pacific is
followed by North America.
Some
of the key players that fuel the growth of the Foot and Mouth Disease (FMD)
Vaccine industry comprise Ceva, SEPPIC, Bayer HealthCare, Inovio
Pharmaceuticals, and Plumbline Life Sciences, Merck, BiogénesisBagó, Indian
Immunologicals, Brilliant Bio Pharma, Boehringer Ingelheim. The leading
companies are taking up partnerships, mergers and acquisitions, and joint
ventures in order to increase the inorganic growth of the industry.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/foot-mouth-disease-fmd-vaccine-market
Market Segment:
Technique
Outlook (Revenue, USD Million, 2014 - 2025)
• Conventional vaccines
• Aluminum hydroxide/Saponin-based vaccines
• Oil-based vaccines
• Emergency vaccines
Animal
Type Outlook (Revenue, USD Million, 2014 - 2025)
• Cattle
• Sheep and Goat
• Pigs
• Others (antelope, deer, bison, camelids)
Regional
Outlook (Revenue, USD Million, 2014 - 2025)
• North America
• Europe
• Asia Pacific
• India
• China
• Japan
• Malaysia
• South Korea
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• South Africa
• Nigeria
• Saudi Arabia
Read more insights on @
https://latestmarkettrends.news.blog
Get in touch
At Million Insights, we work with the aim to reach the highest levels
of customer satisfaction. Our representatives strive to understand diverse
client requirements and cater to the same with the most innovative and
functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: ryan@millioninsights.com
Comments
Post a Comment